Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about NOVARTIS AG
02/26Novartis Signs Development, Distribution Deal With BeiGene For Tislelizumab
MT
02/26NOVARTIS : to Co-Develop Cancer Drug With China's BeiGene
DJ
02/26NOVARTIS : strengthens Oncology pipeline with successful closing of tislelizumab..
PU
02/26NOVARTIS : Gets EU Nod for Label Update of Cosentyx in Psoriatic Arthritis
MT
02/26NOVARTIS : Federal Court Holds Section 8.2 Of The PMNOC Regulations Does Not Imp..
AQ
02/26NOVARTIS : Cosentyx® gains EU label update for first-of-its-kind MAXIMISE data i..
PU
02/22Novartis, Swiss Re, Others Back Switzerland's 2050 Net Zero Climate Goal
MT
02/19NOVARTIS : Gates Foundation to fund Novartis' development of a sickle cell disea..
AQ
02/18NOVARTIS AG : UBS reiterates its Buy rating
MD
02/18NOVARTIS : and the Bill and Melinda Gates Foundation collaborate to discover and..
AQ
02/18NOVARTIS AG : Deutsche Bank reiterates its Buy rating
MD
02/17NOVARTIS : Teams Up With Bill & Melinda Gates Foundation to Develop In Vivo Gene..
MT
02/17NOVARTIS : data show multiple sclerosis patients and nurses prefer Kesimpta Sens..
AQ
02/17NOVARTIS : Entresto granted expanded indication in chronic heart failure by FDA
AQ
02/17NOVARTIS : and Bill & Melinda Gates Foundation collaborate on therapy for sickle..
RE
More most relevant news
All news about NOVARTIS AG
02/26Novartis Signs Development, Distribution Deal With BeiGene For Tislelizumab
MT
02/26NOVARTIS : to Co-Develop Cancer Drug With China's BeiGene
DJ
02/26NOVARTIS : strengthens Oncology pipeline with successful closing of tislelizumab..
PU
02/26NOVARTIS : Gets EU Nod for Label Update of Cosentyx in Psoriatic Arthritis
MT
02/26NOVARTIS : Federal Court Holds Section 8.2 Of The PMNOC Regulations Does Not Imp..
AQ
02/26NOVARTIS : Cosentyx® gains EU label update for first-of-its-kind MAXIMISE data i..
PU
02/25WANTED : more manufacturing space for vaccine push
RE
02/25PRESS RELEASE : Celonic AG : Celonic to Boost its Cell & Gene Therapy Production..
DJ
02/25WANTED : More high-tech manufacturing space for a global vaccine push
RE
02/23Health Care Ticks Down As Investors Await Vaccine Updates -- Health Care Roun..
DJ
More news
News in other languages on NOVARTIS AG
11:23aPresseschau vom Wochenende 09 (27./28. Februar)
02/26Aktien Schweiz Schluss: Inflationssorgen und Gewinnmitnahmen belasten SMI
02/26Bourse Zurich: les indices terminent dans le rouge, entrainés par Wall Street
02/26Aktien Schweiz gehen mit deutlichen Abschlägen ins Wochenende
02/26WOCHENVORSCHAU : Termine bis 12. März 2021
02/26NOVARTIS : finalisation de l'accord avec BeiGene
02/26NOVARTIS : will Krebsmedikament gemeinsam mit Chinas Beigene entwickeln
02/26Novartis finalise l'acquisition d'une licence en oncologie auprès de Beigene
02/26Novartis schliesst Einlizenzierung von Tislelizumab ab
02/26Aktien Schweiz: Erholung auf Vortagesschluss dank Schwergewichten
More news
Analyst Recommendations on NOVARTIS AG
02/18NOVARTIS AG : UBS reiterates its Buy rating
MD
02/18NOVARTIS AG : Deutsche Bank reiterates its Buy rating
MD
02/16NOVARTIS AG : Receives a Buy rating from Deutsche Bank
MD
02/10NOVARTIS AG : Deutsche Bank reiterates its Buy rating
MD
02/09NOVARTIS AG : Deutsche Bank maintains a Buy rating
MD
More recommendations
Press releases
02/26NOVARTIS : strengthens Oncology pipeline with successful closing of tislelizumab..
PU
02/26NOVARTIS : Federal Court Holds Section 8.2 Of The PMNOC Regulations Does Not Imp..
AQ
02/26NOVARTIS : Cosentyx® gains EU label update for first-of-its-kind MAXIMISE data i..
PU
02/19NOVARTIS : Gates Foundation to fund Novartis' development of a sickle cell disea..
AQ
02/18NOVARTIS : and the Bill and Melinda Gates Foundation collaborate to discover and..
AQ
More press releases
Upcoming event on NOVARTIS AG